Leukemia, Lymphoid: all 1,772 studies
Page 13 of 18. Open to participants first (173), then studies with results posted, then the rest; newest registration first within each.
- Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction ImmunochemotherapyTerminatedNCT01625741Phase 2
- Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic LeukemiaCompletedNCT01625143
- NK Cells in Cord Blood TransplantationStatus unknownNCT01619761Phase 1
- Osteonecroses in Pediatric Patients With ALLStatus unknownNCT01619124
- A Study for Older Adults With Acute Lymphoblastic LeukaemiaCompletedNCT01616238Phase 2
- Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLLTerminatedNCT01612988Phase 2
- Effect of Oral Supplementation With a Fibre Enriched Paediatric Sip Feed For Children With Acute Lymphocytic LeukemiaCompletedNCT01600781Not applicable
- Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in ChildrenStatus unknownNCT01593488Phase 2
- Expanded Access Program of PonatinibApproved for marketingNCT01592136
- Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantCompletedNCT01588015Phase 1
- Phase I/II Study of hLL1-DOX in Relapsed NHL and CLLTerminatedNCT01585688Phase 1/2
- Studying Samples From Patients With T-Cell Acute Lymphoblastic LeukemiaCompletedNCT01581528
- A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714)CompletedNCT01580228Phase 3
- Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaCompletedNCT01567709Phase 1
- Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters StudyCompletedNCT01565447
- Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWithdrawnNCT01558778Not applicable
- A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic LeukemiaCompletedNCT01558167Phase 1/2
- Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)CompletedNCT01557777Phase 2
- A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line TherapyCompletedNCT01556776Phase 3
- Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic LeukemiaCompletedNCT01556386
- Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic LeukemiaCompletedNCT01553162
- Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTSCompletedNCT01540812
- Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic LeukemiaCompletedNCT01540578
- IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic LeukemiaCompletedNCT01534715Phase 1
- Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic LeukemiaCompletedNCT01533168
- Evaluation of Efficacy and Safety of Nilotinib in Combination With Chemotherapy in Elderly Patients With Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaCompletedNCT01528085Phase 2
- Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALLCompletedNCT01523977Phase 1
- Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation TreatmentStatus unknownNCT01521689Phase 2
- The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic DiseasesTerminatedNCT01518959Phase 3
- Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic LeukemiaStatus unknownNCT01513603Phase 2
- Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic LeukemiaCompletedNCT01505699
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchTerminatedNCT01500161Phase 2
- Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVEStatus unknownNCT01491763Phase 4
- An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic LeukemiaCompletedNCT01488162
- NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)CompletedNCT01486797Phase 2
- Second Malignant Neoplasms After Childhood ALL TherapyCompletedNCT01476462
- CD19 CAR T Cells for B Cell Malignancies After Allogeneic TransplantCompletedNCT01475058Phase 1/2
- Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007CompletedNCT01470924
- A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)TerminatedNCT01463852Early Phase 1
- Lipoprotein Lipase Expression in Chronic Lymphocytic LeukemiaCompletedNCT01460238
- A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersCompletedNCT01460134Phase 1
- Pilot Study to Establish Safety & Efficacy of a Combination of Dexamethasone and Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL)CompletedNCT01459211Phase 2
- Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic LeukemiaCompletedNCT01457040Phase 2/3
- Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic LeukemiaWithdrawnNCT01456182Phase 1
- Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell TransplantationCompletedNCT01455051Phase 2
- Phase IV Observational Study in Chronic Lymphocytic LeukemiaCompletedNCT01453062
- R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic LymphomaTerminatedNCT01446900Phase 2
- Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell TransplantationCompletedNCT01445132Phase 1
- Endothelial Function, Arterial Stiffness and ComponentsCompletedNCT01439217
- Rituximab+mVPDL for CD20(+) Adult Acute Lymphoblastic LeukemiaStatus unknownNCT01429610Phase 2
- Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic LeukaemiaStatus unknownNCT01423747Phase 3
- ALL-SCT BFM International- HSCT in Children and Adolescents With ALLStatus unknownNCT01423500Phase 3
- Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)CompletedNCT01423032Phase 2/3
- Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)CompletedNCT01419691Phase 2
- Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and RituximabCompletedNCT01416974Phase 1
- Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic LeukemiaCompletedNCT01410513Phase 1
- Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaTerminatedNCT01408160Phase 1
- Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin LymphomaCompletedNCT01403415Phase 1
- Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLLCompletedNCT01400685Phase 1
- Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)CompletedNCT01397916
- Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)TerminatedNCT01397149Phase 1/2
- An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic LeukaemiaCompletedNCT01395615
- PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALLCompletedNCT01393249
- Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to FludarabineCompletedNCT01392079Phase 2
- Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic LeukemiaCompletedNCT01380587
- Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 YearsStatus unknownNCT01376427Not applicable
- Intensified Rituimab Prephase Before FCR in Untreated B-CLLCompletedNCT01370772Phase 2
- Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)Status unknownNCT01366898Phase 4
- Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaCompletedNCT01363817Phase 1
- Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic LeukemiaCompletedNCT01358253Phase 4
- PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 YearsStatus unknownNCT01358201Phase 4
- Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+Status unknownNCT01354457Phase 1/2
- Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and LymphomaTerminatedNCT01352312Phase 1
- Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's MacroglobulinemiaCompletedNCT01351935Phase 1
- Genomic Analysis of Patients With Chronic Lymphocytic LeukemiaActive, not recruitingNCT01346020
- Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic LeukemiaCompletedNCT01331590Early Phase 1
- A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin LymphomaCompletedNCT01328626Phase 1
- Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and TabletsCompletedNCT01324336
- Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)CompletedNCT01324180Phase 1
- Establishment of Acute Lymphocytic Leukemia Data Base in the Department of OncologyStatus unknownNCT01310946
- Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT01310101Phase 2
- RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AMLStatus unknownNCT01307241
- AMG 319 Lymphoid Malignancy FIHCompletedNCT01300026Phase 1
- Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)Status unknownNCT01295593Phase 1/2
- Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic LeukemiaCompletedNCT01295476
- A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins LymphomaCompletedNCT01290549Phase 1
- Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic LeukemiaCompletedNCT01284010
- Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)Status unknownNCT01279707Phase 1/2
- Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)CompletedNCT01279473Phase 1/2
- CLL Empirical Antibiotic RegimenCompletedNCT01279252Phase 2
- Nonmyeloablative Allogeneic TransplantCompletedNCT01272817Not applicable
- A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic LeukaemiaStatus unknownNCT01272440
- Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic LeukemiaWithdrawnNCT01271283Phase 2
- Antiviral Treatment of Chronic Lymphocytic LeukemiaCompletedNCT01255644Phase 4
- Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic LeukaemiaTerminatedNCT01251809Phase 1/2
- Azadirachta Indica in Treating Patients With Chronic Lymphocytic LeukemiaWithdrawnNCT01251250Phase 1
- Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to TreatmentCompletedNCT01246557Phase 1/2
- Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's LymphomaCompletedNCT01230983Phase 3
- An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC)CompletedNCT01224093
- Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)SuspendedNCT01222013Phase 2